Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation

A Mahajan, CN Spracklen, W Zhang, MCY Ng… - Nature …, 2022 - nature.com
We assembled an ancestrally diverse collection of genome-wide association studies
(GWAS) of type 2 diabetes (T2D) in 180,834 affected individuals and 1,159,055 controls …

Identification of type 2 diabetes loci in 433,540 East Asian individuals

CN Spracklen, M Horikoshi, YJ Kim, K Lin, F Bragg… - Nature, 2020 - nature.com
Meta-analyses of genome-wide association studies (GWAS) have identified more than 240
loci that are associated with type 2 diabetes (T2D),; however, most of these loci have been …

Incretin hormones in obesity and related cardiometabolic disorders: the clinical perspective

J Michałowska, E Miller-Kasprzak, P Bogdański - Nutrients, 2021 - mdpi.com
The prevalence of obesity continues to grow rapidly worldwide, posing many public health
challenges of the 21st century. Obese subjects are at major risk for serious diet-related …

New insights into beta-cell GLP-1 receptor and cAMP signaling

A Tomas, B Jones, C Leech - Journal of molecular biology, 2020 - Elsevier
Harnessing the translational potential of the GLP-1/GLP-1R system in pancreatic beta cells
has led to the development of established GLP-1R-based therapies for the long-term …

Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population

K Suzuki, M Akiyama, K Ishigaki, M Kanai, J Hosoe… - Nature …, 2019 - nature.com
To understand the genetics of type 2 diabetes in people of Japanese ancestry, we
conducted A meta-analysis of four genome-wide association studies (GWAS; 36,614 cases …

Glucagon-like peptide-1 receptor blockade impairs islet secretion and glucose metabolism in humans

AA Welch, RA Farahani, AM Egan… - The Journal of …, 2023 - Am Soc Clin Investig
BACKGROUND Proglucagon can be processed to glucagon-like peptide1 (GLP-1) within
the islet, but its contribution to islet function in humans remains unknown. We sought to …

Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY

TW Laver, MN Wakeling, O Knox, K Colclough… - Diabetes, 2022 - Am Diabetes Assoc
Maturity-onset diabetes of the young (MODY) is an autosomal dominant form of monogenic
diabetes, reported to be caused by variants in 16 genes. Concern has been raised about …

Human pluripotent stem cells to model islet defects in diabetes

D Balboa, DG Iworima, TJ Kieffer - Frontiers in Endocrinology, 2021 - frontiersin.org
Diabetes mellitus is characterized by elevated levels of blood glucose and is ultimately
caused by insufficient insulin production from pancreatic beta cells. Different research …

Understanding the place for GLP‐1RA therapy: Translating guidelines for treatment of type 2 diabetes into everyday clinical practice and patient selection

CR Andreasen, A Andersen, FK Knop… - Diabetes, Obesity and …, 2021 - Wiley Online Library
Since the first glucagon‐like peptide 1 (GLP‐1) receptor agonist (GLP‐1RA) was approved
in 2005 (exenatide twice daily) for type 2 diabetes (T2D), the class has developed with …

Earlier age at type 2 diabetes diagnosis is associated with increased genetic risk of cardiovascular disease

H Lee, J Choi, NY Kim, JI Kim, MK Moon, S Lee… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE We investigated genetic risk of cardiovascular disease (CVD) by age at type 2
diabetes (T2D) diagnosis. RESEARCH DESIGN AND METHODS We compared incident …